Randomized multicenter Phase II trial of
✍
Emilio Bajetta; Maria Di Bartolomeo; Luigi Mariani; Antonio Cassata; Salvatore A
📂
Article
📅
2004
🏛
John Wiley and Sons
🌐
English
⚖ 124 KB
👁 1 views
## Abstract ## BACKGROUND The aim of the current randomized Phase II study was to investigate the efficacy and safety of capecitabine combined with irinotecan as first‐line treatment in metastatic colorectal carcinoma (CRC). ## METHODS A total of 140 patients received capecitabine at a dose of 1